On the just-concluded third session of vascular innovation BBS, our company’s research and development engineer Ming He’s "Quick Fenestrater endovascular controllable membrane puncture system" won the favor of judges and won the second prize in the "innovation and creativity competition" held for the first time by BBS.
Our company’s award-winning research and development engineer Ming He (left), honored guest 301 hospital vascular surgery deputy chief physician Xiaohui Ma.
This innovation competition aims to provide opportunities for medical innovators to interact and communicate, and present the best and most valuable innovation projects for top medical investors. With the theme of "innovation", the elite who entered the finals through nationwide selection presented their own innovation and R&D in clinical research, attracting the participation and attention of clinical experts at home and abroad. Experts agree that the competition broadens the minds of the attendees and encourages their enthusiasm for innovation.
More than 700 delegates from the government, hospitals, scientific research institutions, pharmaceutical manufacturers and financial institutions attended the vascular innovation conference. The conference also attracted many international and domestic medical professionals from the United States, Germany, Israel and other countries to give on-site lectures on vascular innovation, deliver cutting-edge technologies in vascular innovation, guide the combination of medical and technological transformation, and build a platform for close communication between clinical experts, policy makers, industry and investment.
Quick Fenestrater award winning product can regulate the rupture of membranes in the lumen for aortic diseases, usually with aortic aneurysm and aortic dissection. This kind of disease often comes on sudden, the illness is dangerous, the mortality rate is high. The most widely used intra-aortic repair procedure at home and abroad has the disadvantages of fatal and disabling complications caused by the destruction of the superior arch artery. The reconstruction of the superior branch of the arch is the most recent treatment method to complete the intracavitary repair. The cavity can regulate the rupture membrane system, which comes from the director team of Lefeng Qu in the long march hospital of the PLA navy. After the completion of innomed, the system can be applied to the reconstruction of the upper branch of the bow with complex lesions, which is safe, effective and fast. The convenient operation mode greatly shortens the operation time, and also improves the safety and treatment effect of the operation.
Award winning product—— Quick Fenestrater endovascular controllable membrane puncture system
In Innomed with the research and development concept of "from clinical to clinical", yinluo continuously launched innovative medical devices with independent intellectual property rights for patients and clinicians.This award shows that innomed people "care about life, continuous innovation" purpose has been effective.
